Results

Total Results: 2,630 records

Showing results for "renal".

  1. hcup-us.ahrq.gov/toolssoftware/comorbidityicd10/CMR-User-Guide-v2025-1.pdf
    November 01, 2024 - (kidney) failure and disease, moderate Yes CMR_RENLFL_SEV Renal (kidney) failure and disease, severe … (kidney) failure and disease, severe, is assigned over Renal (kidney) failure and disease, moderate … measure for Renal failure (RENLFAIL). … In the revised version for ICD-10-CM there are separate measures for moderate and severe renal (kidney … measure for Renal failure (RENLFAIL).
  2. psnet.ahrq.gov/issue/improving-pain-management-hospitalized-medical-patients
    May 01, 2023 - WebM&M Cases Overdose of Gabapentin and Oxycodone in a Patient with End-Stage Renal
  3. www.ahrq.gov/sites/default/files/2024-01/lambert2-report.pdf
    January 01, 2024 - 67.5% of cases; however, rates of appropriate prescribing were lower in subgroups of patients with renal … the changed time course of responses, including patient characteristics, severity of hyperkalemia, renal … It took less time for patients with normal creatinine clearance levels versus those with impaired renal … Being a man, having [K+] higher than 5.3, having normal renal function or severe renal insufficiency … A 60-year-old man with delayed care for a renal mass. JAMA, 305:1890-1898. Schiff, G.D. (2010).
  4. www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/long-term-care/resources/ontime/prevhosp/prevhosp-reports-slides.pptx
    November 30, 2013 - Abdominal/pelvic pain Diarrhea/gastroenteritis Dysphagia GI bleed G tube Hematuria Nausea or vomiting Renal … psychosis Neoplasm Pneumonia Pressure ulcer Peripheral vascular disease Respiratory, other nonpneumonia Renal … profile showing16 active medications during the report week, active high-risk diagnoses of pneumonia and renal … new or worsened urinary incontinence within 7 days of report date and two active high-risk diagnoses: renal … Asthma or COPD Urinary Tract Infection Sepsis or Fever or Infection Dehydration Circulatory Problems* Renal
  5. Table 1 (pdf file)

    hcup-us.ahrq.gov/toolssoftware/comorbidityicd10/TableofChanges2019_1.pdf
    January 01, 2019 - D03122 Melanoma in situ of left lower eyelid, including canthus TUMOR MS DRG 685 ADMIT FOR RENAL
  6. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49696/psn-pdf
    December 01, 2013 - within 1–2 days.(5) TSOACs are cleared, to varying degrees, by the kidneys, and patients with impaired renalRenal insufficiency can delay clearance of anticoagulant effect and TSOACs are not recommended in patients … with severe renal insufficiency (e.g., creatinine clearance Case & Commentary—Part 2 A few hours after … Examples include prescribing TSOACs to a patient with severe renal insufficiency or using TSOACs for
  7. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/48112/psn-pdf
    July 10, 2019 - A WebM&M commentary described a chemotherapy infusion error that caused renal failure.
  8. www.ahrq.gov/es/patient-safety/settings/hospital/vtguide/appb.html
    October 01, 2022 - ONE pharmacologic option |___| Enoxaparin 40 mg SC q 24 hrs |___| Enoxaparin 30 mg SC q 24 hrs (renal … pharmacologic option |___| Enoxaparin 40 mg SC q day |___| Enoxaparin 30 mg SC q 24 hrs  (for renal … insufficiency) |___| Heparin 5,000 units SC q 8 hrs  (end stage renal disease only) |___| Enoxaparin … pharmacologic option |___| Enoxaparin 40 mg SC q 24 hrs |___| Enoxaparin 30 mg SC q 24 hrs (renal … pharmacologic option |___| Enoxaparin 40 mg SC q day |___| Enoxaparin 30 mg SC q 24 hrs (for renal
  9. www.ahrq.gov/patient-safety/settings/hospital/vtguide/appb.html
    October 01, 2022 - ONE pharmacologic option |___| Enoxaparin 40 mg SC q 24 hrs |___| Enoxaparin 30 mg SC q 24 hrs (renal … pharmacologic option |___| Enoxaparin 40 mg SC q day |___| Enoxaparin 30 mg SC q 24 hrs  (for renal … insufficiency) |___| Heparin 5,000 units SC q 8 hrs  (end stage renal disease only) |___| Enoxaparin … pharmacologic option |___| Enoxaparin 40 mg SC q 24 hrs |___| Enoxaparin 30 mg SC q 24 hrs (renal … pharmacologic option |___| Enoxaparin 40 mg SC q day |___| Enoxaparin 30 mg SC q 24 hrs (for renal
  10. www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/long-term-care/intervention-worksheet.pdf
    June 01, 2021 - • Dose recommendations for residents with decreased renal function.
  11. hcup-us.ahrq.gov/toolssoftware/ccsr/DXCCSR-vs-Beta-CCS-Comparison.pdf
    January 01, 2020 - pelvis NEO044 Urinary system cancers - ureter and renal pelvis 9 6 3 33 Cancer of kidney and renal … pelvis 4 NEO044 – Urinary system cancers - ureter and renal pelvis NEO045 – Urinary system cancers … - kidney 34 Cancer of other urinary organs 4 NEO044 – Urinary system cancers - ureter and renal pelvis … sclerosis 6 GEN001 – Nephritis; nephrosis; renal sclerosis 157 Acute and unspecified renal failure … 1 GEN002 – Acute and unspecified renal failure 158 Chronic kidney disease 5 GEN003 – Chronic kidney
  12. www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/cauti-tools/archived-webinars/ed-catheter-insertions-091013.ppt
    January 01, 2010 - Catheter Placement Elderly (especially women) Incontinence Debility Use in non-critically ill cardiac and renal … inappropriate catheterization Elderly Women Incontinent Obese Immobile Non-critically ill cardiac and renal … inappropriate placement include those who are incontinent, obese, immobile, and patients with cardiac or renal …   Insert catheter and treat signs of shock: Hypotension Decreased cardiac output/function Decreased renal
  13. hcup-us.ahrq.gov/reports/factsandfigures/2007/exhibit5_9.jsp
    January 01, 2007 - disorders) 147 193 31.0 36.3 32 Genitourinary 152 195 100.0 100.0 28 Acute renal … Medicaid hospital stays for some conditions more than doubled from 1997 to 2007: Acute renal failure
  14. hcup-us.ahrq.gov/reports/factsandfigures/2007/exhibit5_8.jsp
    January 01, 2007 - problems) 163 234 25.3 24.9 44 Genitourinary 602 865 100.0 100.0 44 Acute renal … Hospital stays for some conditions billed to Medicare more than doubled from 1997 to 2007: Acute renal
  15. hcup-us.ahrq.gov/reports/factsandfigures/2008/figures/2008_4_2.jsp
    January 01, 2008 - AVERAGE ANNUAL GROWTH IN DISCHARGES PER POPULATION AVERAGE ANNUAL GROWTH IN POPULATION Acute renal
  16. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/35771/psn-pdf
    May 27, 2011 - For instance, the capacity to provide renal drug dosing, specific drug guidance, and mechanisms for
  17. hcup-us.ahrq.gov/reports/infographics/HCUP-hospital-readmission-infographic-final.pdf
    July 15, 2014 - diagnoses was readmitted: 25% Congestive heart failure 22% Schizophrenia 22% Acute and unspecified renal
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
    January 01, 2010 - with DES plus a selected group of clinically important variables including: gender, age, diabetes, renal … As expected, mortality was higher in those with diabetes, renal failure, STEMI or CHF. … This effect was somewhat less pronounced in those with a prior history of CABG and renal failure, with … Similarly, the 30-month risk of MI was lower in all patient subgroups except those with renal failure … (Figure 4c) However, no benefit was observed in patients >75 years, or with diabetes, renal failure,
  19. digital.ahrq.gov/sites/default/files/docs/publication/u19hs021094-bates-final-report-2017.pdf
    January 01, 2017 - Data for drug-drug interaction, drug allergy, duplicate medication, renal, geriatric, and formulary … The rates of inappropriate overrides were highest for DDI, age-based, and renal substitutions, which … Brigham and  Women’s Hospital HIT-­‐CERT inappropriate override rates highest for age and renal based … Age-based Substitution 10,501 6.7% 8,297 79.0% 39 Patient has tolerated this drug in the past Renal … Of those who received at least 10 renal recommendations, 36 of 92 (39%) overrode ≥ 90% of the alerts
  20. TND-555-09-03-2013 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-555-09-03-2013.pdf
    January 01, 2013 - Completion Date: 02-13-2013 3 Control and Complications Trial (DCCT) (as measured by retinal, renal … A decrease in or prevention of diabetes-related complications (as measured by retinal, renal, cardiovascular